Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages

European Heart Journal

Volumn 32, Issue 22, 2011, Pages 2841-2850

  Borrell Pags, Maria ^a   Romero, July Carolina ^a   Juan Babot, Oriol ^a   Badimon, Lina ^a  

^a CSIC   (Spain)

Author keywords

Atherosclerosis; Human macrophages; Lipid uptake; LRP5; Wnt signalling

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CYCLIN D1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; OSTEOPONTIN; PROTEIN C JUN; WNT PROTEIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; FOAM CELL; HUMAN; HUMAN CELL; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

APOPTOSIS; ATHEROSCLEROSIS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; FOAM CELLS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MACROPHAGES; MONOCYTES; OSTEOPONTIN; RNA, MESSENGER; RNA, SMALL INTERFERING; WNT SIGNALING PATHWAY;

EID: 80052782624     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr062     Document Type: Article

References (38)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;23: 242-250.
2. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G. Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol 1997;17:1011-1017. (Pubitemid 27260317)
3. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res 1989;30:967-978. (Pubitemid 19183948)
4. Williams KJ. Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr Opin Lipidol 2001;12:477-487. (Pubitemid 32980295)
5. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low-density-lipoprotein after self-aggregation. Arteriosclerosis 1988;8:348-358.
6. Zhang WY, Ishii I, Kruth HS. Plasmin-mediated macrophage reversal of low-density-lipoprotein aggregation. J Biol Chem 2000;275:33176-33183.
7. Kruth HS. Sequestration of aggregated low-density-lipoproteins by macrophages. Curr Opin Lipidol 2002;13:483-488.
8. Tertov VV, Orekhov AN, Sobenin IA, Gabbasov ZA, Popov EG, Yaroslavov AA, Smirnov VN. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res 1992;71: 218-228.
9. Llorente-Cortés V, Mart́nez-González J, Badimon L. LDL-receptor-relatedprotein mediates uptake of aggregated LDL in HVSMC. Arterioscler Thromb Vasc Biol 2000;20:1572-1579. (Pubitemid 30353890)
10. Llorente-Cortés V, Otero-Viñas M, Sánchez S, Rodŕguez C, Badimon L. Low-density-lipoprotein upregulates low-density lipoprotein-receptor-related protein expression in VSMC: possible involvement of SRBP-2-dependent mechanism. Circulation 2002;106:3104-3110. (Pubitemid 35440296)
11. Llorente-Cortés V, Otero-Viñas M, Camino-López S, Costales P, Badimon L. Cholesteryl esters of aggregated-LDL are internalized by selective uptake in HVSMC. Arterioscler Thromb Vasc Biol 2006;26:117-123. (Pubitemid 43732237)
12. Hiltunen TP, Luoma JS, Nikkari T, Ylä-Herttuala S. Expression of LDL-receptor, VLDL-receptor, LDL-receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL-receptor expression during lesion development. Circulation 1998;97: 1079-1086.
13. Llorente-Cortés V, Otero-Viñas M, Berrozpe M, Badimon L. Intracellular lipid accumulation, low-density-lipoprotein-receptor-related protein expression, and cell survival in VSMC derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 2004;34:182-190. (Pubitemid 38406632)
14. Llorente-Cortés V, Royo T, Otero-Viñas M, Berrozpe M, Badimon L. Sterol regulatory element binding proteins downregulate LRP1 expression and LRP1-mediated aggregated LDL uptake by human macrophages. Cardiovasc Res 2007;74:526-536. (Pubitemid 46693710)
15. Mao J,Wang J, Liu B, PanW, Farr G, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. LRP5 binds to axin and regulates the canonical Wnt signaling pathway. Mol Cell 2001;7:801-809.
16. Johnson ML. The high bone mass family-the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 2004;4:135-138. (Pubitemid 38877763)
17. Howe LR, Subbaramaia K, Chung WJ, Dannenberg AJ, Brown AM. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 1999;59:1572-1577. (Pubitemid 29160128)
18. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C. Target genes of beta-catenin-T cellfactor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-1608. (Pubitemid 29098498)
19. Van Der Heyden MA, Rook MB, Hermans MM, Rijksen G, Boonstra J, Defize LH, Destree OH. Identification of connexin 43 as a functional target for Wnt signalling. J Cell Sci 1998;111:1741-1749. (Pubitemid 28330560)
20. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclinD1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527. (Pubitemid 29234650)
21. Müller T, Bain G, Wang X, Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res 2002;280:119-133. (Pubitemid 35230373)
22. Dell'Accio F, De Bari C, El Tawil NM, Barone F, Mitsiadis TA, O'Dowd J, Pitzalis C. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 2006;8:139.
23. Sakr SW, Eddy RJ, Barth H, Wang F, Greenberg S, Maxfield FR, Tabas I. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity. J Biol Chem 2001;276:37649-37658.
24. Morita SY, Kawabe M, Sakurai A, Okuhira K, Vertut-DöA, Nakano M, Handa T. Ceramide in lipid particles enhances heparan-sulfate proteoglycan and low-density-lipoprotein-receptor-related protein-mediated uptake by macrophages. J Biol Chem 2004;279:24355-24361. (Pubitemid 38725298)
25. Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 2009;76:S27-S30.
26. Qiu W, Hu Y, Andersen TE, Jafari A, Li N, Chen W, Kassem M. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical WNT signaling and C/EBP. J Biol Chem 2010;285:14438-14449.
27. HaÿE, Nouraud A, Marie PJ. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PLoS One 2009;4:e8284.
28. Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturk M. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer 2009;8:90.
29. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003. (Pubitemid 34219753)
30. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009;3:311-322.
31. Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993; 91:1800-1809. (Pubitemid 23127387)
32. de Kleijn DP, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, Daemen MJ, Biessen EA, de Jager W, Zhang H, de Vries JP, Falk E, Lim SK, van der Spek PJ, Sze SK, Pasterkamp G. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010; 30:612-9.
33. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 2010;285:8218-8226.
34. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA. CyclinD1/cyclin-dependent kinase-4 interacts with filamin-A and affects the migration and invasion potential of breast cancer cells. Cancer Res 2010;70:2105-2114.
35. Webb NR, Moore KJ. Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr Drug Targets 2007;8: 1249-1263.
36. Choudhury RP, Lee JM, Greaves DR. Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med 2005;2:309-315. (Pubitemid 40852635)
37. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, Takada S, Kim DH, Kamataki A, Magoori K, Miyamoto Y, Oishi H, Nose M, Okazaki M, Usui S, Imaizumi K, Yanagisawa M, Sakai J, Yamamoto TT. LRP5 is essential for normal cholesterol metabolism and glucose-induced secretion. Proc Natl Acad Sci USA 2003;100: 229-234.
38. Magoori K, Kang MJ, Ito MR, Kakuuchi H, Ioka RX, Kim DH, Asaba H, Iwasaki S, Takei YA, Takahashi S, Ono M, Nose M, Sakai J, Fujino T, Yamamoto TT. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both LRP5 and apolipoprotein E. J Biol Chem 2003;278: 11331-11336. (Pubitemid 36792690)